Home

finanţa mită accident vascular cerebral pai1 Dolar Primul Retenţie

JCI - PAI1 mediates fibroblast–mast cell interactions in skin fibrosis
JCI - PAI1 mediates fibroblast–mast cell interactions in skin fibrosis

Plasminogen Activator Inhibitor-1 and Oncogenesis in the Liver Disease
Plasminogen Activator Inhibitor-1 and Oncogenesis in the Liver Disease

Frontiers | Premature delivery impacts the concentration of plasminogen  activators and a plasminogen activator inhibitor and the plasmin activity  in human milk
Frontiers | Premature delivery impacts the concentration of plasminogen activators and a plasminogen activator inhibitor and the plasmin activity in human milk

Biomolecules | Free Full-Text | The TGF-β1/p53/PAI-1 Signaling Axis in  Vascular Senescence: Role of Caveolin-1
Biomolecules | Free Full-Text | The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1

JCI - Interacting hepatic PAI-1/tPA gene regulatory pathways influence  impaired fibrinolysis severity in obesity
JCI - Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity

PAI1 Monoclonal Antibody (242816) (MA5-23790)
PAI1 Monoclonal Antibody (242816) (MA5-23790)

PAI-1 and TGF-β | Arteriosclerosis, Thrombosis, and Vascular Biology
PAI-1 and TGF-β | Arteriosclerosis, Thrombosis, and Vascular Biology

Mouse PAI1 Total ELISA Kit (ab157529) | Abcam
Mouse PAI1 Total ELISA Kit (ab157529) | Abcam

Plasminogen Activator Inhibitor-1 and Oncogenesis in the Liver Disease
Plasminogen Activator Inhibitor-1 and Oncogenesis in the Liver Disease

Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic  Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome |  Arteriosclerosis, Thrombosis, and Vascular Biology
Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome | Arteriosclerosis, Thrombosis, and Vascular Biology

PAI1 Monoclonal Antibody (MA-33H1F7) (MA1-40224)
PAI1 Monoclonal Antibody (MA-33H1F7) (MA1-40224)

IJMS | Free Full-Text | Thrombin Upregulates PAI-1 and  Mesothelial–Mesenchymal Transition Through PAR-1 and Contributes to  Tuberculous Pleural Fibrosis
IJMS | Free Full-Text | Thrombin Upregulates PAI-1 and Mesothelial–Mesenchymal Transition Through PAR-1 and Contributes to Tuberculous Pleural Fibrosis

Role of plasminogen activator inhibitor-1 in methotrexate-induced  epithelial-mesenchymal transition in alveolar epithelial A549 cells -  ScienceDirect
Role of plasminogen activator inhibitor-1 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cells - ScienceDirect

Plasminogen activator inhibitor-1 (PAI-1) deficiency
Plasminogen activator inhibitor-1 (PAI-1) deficiency

LDR-Induced miR-30a and miR-30b Target the PAI-1 Pathway to Control Adverse  Effects of NSCLC Radiotherapy: Molecular Therapy
LDR-Induced miR-30a and miR-30b Target the PAI-1 Pathway to Control Adverse Effects of NSCLC Radiotherapy: Molecular Therapy

Recombinant Anti-PAI1 antibody [EPR21850-82] (ab222754) | Abcam
Recombinant Anti-PAI1 antibody [EPR21850-82] (ab222754) | Abcam

Schematic representation of PAI-1 action. PAI-1 not only inhibits local...  | Download Scientific Diagram
Schematic representation of PAI-1 action. PAI-1 not only inhibits local... | Download Scientific Diagram

Journal of Cellular Physiology | Cell Biology Journal | Wiley Online Library
Journal of Cellular Physiology | Cell Biology Journal | Wiley Online Library

Plasminogen activator inhibitor 1 (PAI-1) and fibrinolytic pathway |  Download Scientific Diagram
Plasminogen activator inhibitor 1 (PAI-1) and fibrinolytic pathway | Download Scientific Diagram

IJMS | Free Full-Text | PAI-1: A Major Player in the Vascular Dysfunction  in Obstructive Sleep Apnea?
IJMS | Free Full-Text | PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?

Complete plasminogen activator inhibitor 1 deficiency: MedlinePlus Genetics
Complete plasminogen activator inhibitor 1 deficiency: MedlinePlus Genetics

Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts  with paracrine effects promoting esophageal squamous cell carcinoma  progression and causing chemoresistance | Cell Death & Disease
Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance | Cell Death & Disease

Plasminogen Activator Inhibitor-1 (PAI-1): Regulator of clotting
Plasminogen Activator Inhibitor-1 (PAI-1): Regulator of clotting

Schematic diagram showing functional roles of PAI-1 and uPA during... |  Download Scientific Diagram
Schematic diagram showing functional roles of PAI-1 and uPA during... | Download Scientific Diagram

Plasminogen activator inhibitor 1 and gestational diabetes: the causal  relationship | Diabetology & Metabolic Syndrome | Full Text
Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship | Diabetology & Metabolic Syndrome | Full Text